FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/04/024796 [Registered on: 22/04/2020] Trial Registered Prospectively
Last Modified On: 14/04/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Is 1% lignocaine drug similar to 2% lignocaine when used in airway anaesthesia in a routine bronchoscopy procedure? 
Scientific Title of Study   Randomized controlled trial to study efficacy of 1% vs 2% lignocaine in topical airway anaesthesia in routine bronchoscopy procedures 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Danny Prasad 
Designation  Junior Resident 
Affiliation  CMC,Vellore 
Address  Respiratory Medicine Dept 7th floor,ISSCC building CMC Vellore Vellore

Vellore
TAMIL NADU
632004
India 
Phone  8427668064  
Fax    
Email  dannyprasad29@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prince James 
Designation  Professor 
Affiliation  CMC,Vellore 
Address  Respiratory Medicine Dept 7th floor,ISSCC building CMC Vellore

Vellore
TAMIL NADU
632004
India 
Phone  9600771709  
Fax    
Email  drprincej@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prince James 
Designation  Professor 
Affiliation  CMC,Vellore 
Address  Respiratory Medicine 7th floor,ISSCC building CMC Vellore

Vellore
TAMIL NADU
632004
India 
Phone  9600771709  
Fax    
Email  drprincej@gmail.com  
 
Source of Monetary or Material Support  
Fluid research grant 
 
Primary Sponsor  
Name  Dr Prince James 
Address  Dr Prince James Professor Respiratory Medicine CMC Vellore Vellore Tamil Nadu-632004  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Major Danny Prasad  Christian Medical college Vellore  Room no.1 Bronchoscopy suite Near K ward Respiratory Medicine Christian Medical college,Vellore
Vellore
TAMIL NADU 
8427668064

dannyprasad29@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee,Institutional review board   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J00-J99||Diseases of the respiratory system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  1% lignocaine used as spray as you go technique  1% lignocaine will be used for topical airway anaesthesia as a spray as you go technique in routine bronchoscopy procedure 
Comparator Agent  2% lignocaine used as a spray as you go technique   2% lignocaine will be used as a spray as you technique for topical airway anaesthesia in routine bronchoscopy procedure 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  Consecutive patients undergoing flexible bronchoscopy during study period will be considered
eligible for inclusion if they are
1.Aged above 18 years
2.Hemodynamically stable(defined systolic B.P>100mmHg,<180mmHg)
 
 
ExclusionCriteria 
Details  1. Failure to provide informed consent
2. Documented history of lignocaine toxicity
3. Pregnancy
4. Patients undergoing TBNA and other interventions
5. Wherein bronchoscopy was performed through endotracheal or tracheostomy tube
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the cough scores during the procedure between two study groups that is 1% lignocaine and 2% lignocaine by using VAS score(0-100mm)  1.Immediately after procedure- Cough score as assessed by bronchoscopist,respiratory therapist and staff nurse assisting the procedure
2.Two hours after procedure-cough score as assessed by patient 
 
Secondary Outcome  
Outcome  TimePoints 
To determine overall feel of scopy as assessed by patient based on FACES pain scale score   within 2 hours of procedure 
To determine overall feel of scopy for the operator based on VAS score(0-100mm scale)  immediately after the procedure 
To determine total dose of lignocaine (in mg) used while performing procedure for 1% vs 2% concentrations  immediately after the procedure 
To determine overall complication rate in number while undergoing bronchoscopy procedures in 1% vs 2% lignocaine  immediately after the procedure 
 
Target Sample Size   Total Sample Size="500"
Sample Size from India="500" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   01/05/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   The aim of this study is to compare the efficacy  of two lignocaine strengths that is 1% and 2% in suppressing cough in patients undergoing routine brochoscopy procedures in our hospital setting.Also the study aims at comparing  its effect on overall satisfaction of bronchoscopist ,with regards to conduct of the procedure as well as overall satisfaction of patient during the procedure.The optimal concentration of lignocaine to be used in flexible bronchoscopy remains unknown.This randomized controlled trial will try to compare the efficacy of 1% and 2% lignocaine solutions  for topical airway anaesthesia during routine bronchoscopy.Patient s will be recruited from outpatient and inpatients under respiratory and pulmonary medicine and the study will be conducted in the bronchoscopy suite of CMC Vellore hospital.It will be conducted as a investigator,patient,outcome asessor,daty entry operator blinded RCT .The main primary outcome is cough score as rated by the operator using VAS scores 
Close